Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 3, 2013, Pages 263-271

  McElrath, M J ^a,b   Smythe, K ^a   Randolph Habecker, J ^a   Melton, K R ^a   Goodpaster, T A ^a   Hughes, S M ^c   MacK, M ^d   Sato, A ^a   Diaz, G ^a   Steinbach, G ^a,b   Novak, R M ^e   Curlin, M ^a   Lord, J D ^f   Maenza, J ^a,b   Duerr, A ^a,b   Frahm, N ^a,b   Hladik, Florian ^a,b,c  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e UNIVERSITY OF ILLINOIS   (United States)

^f VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

CCR5; Colon; Gut; HIV; Immunohistochemistry; Macrophages; Mucosa; Rectum; T cells

Indexed keywords

CD209 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR5;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL DENSITY; CLINICAL ARTICLE; COLON; COMPARATIVE STUDY; DENDRITIC CELL; DISEASE PREDISPOSITION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM; T LYMPHOCYTE; TARGET CELL;

ADULT; ANAL CANAL; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DENDRITIC CELLS; GASTROINTESTINAL TRACT; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, CCR5; SEXUAL BEHAVIOR; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 84880249764     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182898392     Document Type: Article

References (56)

1. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol. 2008;8:447-457.
2. Gross M, Holte SE, Marmor M, et al. Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr. 2000;24: 393-398.
3. Exner TM, Correale J, Carballo-Dieguez A, et al. Women's anal sex practices: implications for formulation and promotion of a rectal micro-bicide, AIDS Educ Prev. 2008;20:148-159.
4. Schwandt M, Morris C, Ferguson A, et al. Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. Sex Transm Infect. 2006;82:392-396.
5. McGowan I, Taylor DJ. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies. Sex Transm Dis. 2010;37:361-364.
6. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39:1048-1063.
7. Boily MC, Baggaley RF, Masse B. The role of heterosexual anal intercourse for HIV transmission in developing countries: are we ready to draw conclusions? Sex Transm Infect. 2009;85:408-410.
8. Ribeiro Dos Santos P, Rancez M, Pretet JL, et al. Rapid dissemination of SIV follows multisite entry after rectal inoculation. PLoS One. 2011;6:e19493.
9. Louissaint NA, Nimmagadda S, Fuchs EJ, et al. Distribution of cell-free and cell-associated HIV surrogates in the colon after simulated receptive anal intercourse in men who have sex with men. J Acquir Immune Defic Syndr. 2012;59:10-17.
10. McKinnon LR, Kaul R. Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Curr Opin HIV AIDS. 2012;7:195-202.
11. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science. 1998;280:427-431.
12. Smit-McBride Z, Mattapallil JJ, McChesney M, et al. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J Virol. 1998;72:6646-6656.
13. Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004;200:761-770.
14. Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection, Nature. 2005;434:1093-1097.
15. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol. 2003;77:11708-11717.
16. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200:749-759.
17. Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature. 2005; 434:1148-1152.
18. Mehandru S, Poles MA, Tenner-Racz K, et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol. 2007;81:599-612.
19. Poles MA, Elliott J, Taing P, et al. A preponderance of CCR5(+) CXCR4 (+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol. 2001;75: 8390-8399.
20. Anton PA, Elliott J, Poles MA, et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS. 2000;14:1761-1765.
21. Smith PD, Meng G, Sellers MT, et al. Biological parameters of HIV-1 infection in primary intestinal lymphocytes and macrophages. J Leukoc Biol. 2000;68:360-365.
22. Shen R, Richter HE, Clements RH, et al. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J Virol. 2009;83:3258-3267.
23. Shen R, Meng G, Ochsenbauer C, et al. Stromal down-regulation of macrophage CD4/CCR5 expression and NF-kappaB activation mediates HIV-1 non-permissiveness in intestinal macrophages. PLoS Pathog. 2011;7:e1002060.
24. Meng G, Sellers MT, Mosteller-Barnum M, et al. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J Infect Dis. 2000;182:785-791.
25. Li L, Meng G, Graham MF, et al. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5. Gastroenterology. 1999;116:1043-1053.
26. Meng G, Wei X, Wu X, et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med. 2002;8: 150-156.
27. Shen R, Smythies LE, Clements RH, et al. Dendritic cells transmit HIV-1 through human small intestinal mucosa. J Leukoc Biol. 2009;87: 663-670.
28. Gurney KB, Elliott J, Nassanian H, et al. Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. J Virol. 2005;79:5762-5773.
29. McGowan I, Elliott J, Cortina G, et al. Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056). J Acquir Immune Defic Syndr. 2007;46:417-425.
30. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372:1881-1893.
31. McElrath MJ, De Rosa SC, Moodie Z, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet. 2008;372:1894-1905.
32. Smith PD, Meng G, Salazar-Gonzalez JF, et al. Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J Leukoc Biol. 2003; 74:642-649.
33. Varadarajan N, Julg B, Yamanaka YJ, et al. A high-throughput single-cell analysis of human CD8+ T cell functions reveals discordance for cytokine secretion and cytolysis. J Clin Invest. 2011;121: 4322-4331.
34. Bendall SC, Simonds EF, Qiu P, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science. 2011;332:687-696.
35. Smith PD, Smythies LE, Shen R, et al. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol. 2011;4:31-42.
36. Mowat AM, Bain CC. Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun. 2011;3:550-564.
37. Fletcher PS, Elliott J, Grivel JC, et al. Ex vivo culture of human colo-rectal tissue for the evaluation of candidate microbicides. AIDS. 2006;20: 1237-1245.
38. Souza HS, Elia CC, Spencer J, et al. Expression of lymphocyte-endothe- lial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 1999;45:856-863.
39. Chen YB, Kim HT, McDonough S, et al. Up-regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15: 1066-1076.
40. Arthos J, Cicala C, Martinelli E, et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol. 2008;9:301-309.
41. Cicala C, Martinelli E, McNally JP, et al. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A. 2009;106: 20877-20882.
42. Grivel JC, Elliott J, Lisco A, et al. HIV-1 pathogenesis differs in recto-sigmoid and tonsillar tissues infected ex vivo with CCR5-and CXCR4-tropic HIV-1. AIDS. 2007;21:1263-1272.
43. Cranage M, Sharpe S, Herrera C, et al. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med. 2008;5:e157; discussion e157.
44. Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP, et al. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One. 2010;5:e9310.
45. Abner SR, Guenthner PC, Guarner J, et al. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis. 2005;192:1545-1556.
46. Herrera C, Cranage M, McGowan I, et al. Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants. AIDS. 2011;25:1971-1979.
47. Anton PA, Saunders T, Elliott J, et al. First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy. PLoS One. 2011;6:e23243.
48. Zhang L, He T, Talal A, et al. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol. 1998;72:5035-5045.
49. Sonnenberg GF, Monticelli LA, Elloso MM, et al. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity. 2011;34:122-134.
50. Jiang Y, Zhang Z, Diao Y, et al. Expression of chemokine receptors on natural killer cells in HIV-infected individuals. Cell Immunol. 2008;251: 19-24.
51. Bernstein HB, Wang G, Plasterer MC, et al. CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function. Virology. 2009;387:59-66.
52. Ariel A, Fredman G, Sun YP, et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol. 2006;7:1209-1216.
53. Mack M, Kleinschmidt A, Bruhl H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med. 2000;6:769-775.
54. Hendrix CW, Cao YJ, Fuchs EJ. Topical microbicides to prevent HIV: clinical drug development challenges. Annu Rev Pharmacol Toxicol. 2009;49:349-375.
55. Patterson KB, Prince HA, Kraft E, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3:112-114.
56. Rao S, Hu S, McHugh L, et al. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci U S A. 2005;102:11993-11998.